MedPath

Comparative Investigation on the in vitro susceptibility of Propionibacterium acnes (P. acnes) against nadifloxacin, erythromycin, clindamycin and tetracycline

Conditions
L70.0
Acne vulgaris
Registration Number
DRKS00014231
Lead Sponsor
Dr. R. Pfleger GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
115
Inclusion Criteria

Acne vulgaris in facial area

Exclusion Criteria

laboratory study, therefore no exclusion criteria defined

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
aboratory study, patients will not be treated, solely collection of Skin swabs - therefore no Primary outcome is defined.
Secondary Outcome Measures
NameTimeMethod
see Explanation Primary outcome
© Copyright 2025. All Rights Reserved by MedPath